Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products... Show more
The Aroon Indicator for HKMPY entered a downward trend on October 02, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 166 similar instances where the Aroon Indicator formed such a pattern. In of the 166 cases the stock moved lower. This puts the odds of a downward move at .
The 10-day RSI Indicator for HKMPY moved out of overbought territory on October 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on October 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HKMPY as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HKMPY turned negative on October 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HKMPY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HKMPY broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
HKMPY moved above its 50-day moving average on October 02, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HKMPY crossed bullishly above the 50-day moving average on October 09, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HKMPY advanced for three days, in of 80 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.071) is normal, around the industry mean (17.681). P/E Ratio (14.214) is within average values for comparable stocks, (72.923). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.078). Dividend Yield (0.035) settles around the average of (0.030) among similar stocks. P/S Ratio (1.645) is also within normal values, averaging (46.505).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HKMPY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HKMPY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Industry PharmaceuticalsGeneric
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HILGX | 12.00 | 0.05 | +0.42% |
Hennessy Cornerstone Large Growth Instl | |||
NEFJX | 20.75 | 0.04 | +0.19% |
Natixis Vaughan Nelson Small Cap A | |||
CICAX | 66.45 | 0.10 | +0.15% |
American Funds Invmt Co of Amer 529A | |||
LIDCX | 9.68 | -0.01 | -0.10% |
Lord Abbett International Value C | |||
TGVRX | 32.16 | -0.28 | -0.86% |
Thornburg International Equity R3 |
A.I.dvisor tells us that HKMPY and HROW have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPY and HROW's prices will move in lockstep.
Ticker / NAME | Correlation To HKMPY | 1D Price Change % | ||
---|---|---|---|---|
HKMPY | 100% | -0.83% | ||
HROW - HKMPY | 23% Poorly correlated | +5.51% | ||
CXXIF - HKMPY | 22% Poorly correlated | -2.03% | ||
HYPMY - HKMPY | 14% Poorly correlated | -2.49% | ||
ETST - HKMPY | 10% Poorly correlated | -4.00% | ||
INDV - HKMPY | 8% Poorly correlated | -0.85% | ||
More |
Ticker / NAME | Correlation To HKMPY | 1D Price Change % |
---|---|---|
HKMPY | 100% | -0.83% |
Pharmaceuticals: Generic industry (219 stocks) | 10% Poorly correlated | -0.27% |